Multiple forms of TGF-β1 in breast tissue: A biologically active form of the small latent complex of TGF-β1

European Journal of Cancer Part A

Volumn 32, Issue 9, 1996, Pages 1566-1573

  Baillie, R ^a,b   Coombes, R C ^a   Smith, J ^a,c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breast cancer; Latent complex; Oestrogen receptor; Proliferation; TGF 1

Indexed keywords

TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030218867     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00115-3     Document Type: Article

References (33)

1. 1. Plotkin D, Lecher J, Jung WE, Risen PJ. Tamoxifen flare in advanced breast cancer. JAMA 1978, 240, 2644-2646.
2. 2. Roberts AB, Frolik CA, Anzano MA, Sporn MB. Transforming growth factors from neoplastic and non-neoplastic tissues. Fed Proc 1983, 42, 2621-2626.
3. 3. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990, 63, 245-247.
4. 4. Roberts AB, Sporn MB. The transforming growth factors-β. In Sporn MB, Roberts AB, eds. Handbook of Experimental Pharmacology. Springer-Verlag, New York, 1990, 419-472.
5. 5. Lawrence DA, Pircher R, Krycene-Martiniere C, Julien P. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 1984, 121, 184-188.
6. 6. Smith J, McLachlan JC. Identification of a novel growth factor with transforming activity secreted by individual chick embryos. Development 1990, 109, 905-910.
7. 7. Derynck R, Jarrett A, Chen EY, Goeddel DV. The murine transforming growth factor-β precursor. J Biol Chem 1986, 261, 4377-4379.
8. 1. J Biol Chem 1988, 263, 6407-6417.
9. 1. Cancer Res 1987, 47, 6451-6458.
10. 10. Pircher R, Julien P, Lawrence D. A β-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun 1986, 136, 30-37.
11. 1 in the human mammary gland. Cancer Res 1991, 51, 4685-4692.
12. 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res 1992, 52, 4261-4264.
13. 1 to the advancing edges of primary tumors and to lymph nodes of human mammary carcinoma. Am J Pathol 1993, 143, 381-389.
14. 14. Barrett-Lee PJ, Travers MT, Luqmani Y, Coombes RC. Transcripts for transforming growth factors in human breast cancer: clinical correlates. Br J Cancer 1990, 61, 612-617.
15. 15. Ethier SP, Van de Velde. Secretion of a TGF-β like growth inhibitor by normal rat mammary epithelial cells. J Cell Physiol 1990, 142, 15-20.
16. 16. Lippman ME, Dickson RB. Growth control of normal and malignant breast epithelium. Proc R Soc Edinburgh 1989, 95b, 89-106.
17. 17. Arrick BA, Korc M, Derynck R. Differential regulation of expression of three transforming growth factor-β species in human breast cancer cell lines with estradiol. Cancer Res 1990, 50, 2996-3030.
18. 18. Colletta AA, Wakefield LM, Howell KEP, et al. Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer 1991, 62, 405-409.
19. 19. Wakefield LM, Kim S-J, Glick A, Winokur T, Colletta A, Sporn MB. Regulation of transforming growth factor b subtypes by members of the steroid hormone superfamily. J Cell Sci 1990, S13, 139-148.
20. 1 gene. J Biol Chem 1992, 267, 13702-13707.
21. 21. Smith J, Yelland A, Baillie B, Coombes RC. Acidic and basic fibroblast growth factors in human breast tissue. Eur J Cancer 1994, 30A, 496-503.
22. 22. Smith J, Chander SK, Baillie R, Coombes RC. The effect of endocrine therapy on fibroblast growth factor-like activity in nitrosomethyl urea induced rat mammary tumours. Eur J Cancer 1993, 29A, 2125-2131.
23. 23. Smith J, McLachlan JC. Developmental pattern of growth factor production in chick embryo limb buds. J Anat 1989, 165, 159-168.
24. 24. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principles of protein dye binding. J Biol Chem 1985, 260, 11389-11392.
25. 25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
26. 26. Harlow E, Lane D. Immunoprecipitation. In Antibodies: A Laboratory Manual. Cold Spring Harbor, 1988, 421-471.
27. 27. Wu RS, Stedman JD, West MHP, Pantazis P, Bonner WM. Discontinuous agarose electrophoretic system for the recovery of stained proteins from polyacrylamide gels. Anal Biochem 1982, 124, 264-271.
28. 28. Ellingsworth LR, Brennan JE, Fok K, et al. Antibodies to the n-terminal portion of cartilage-inducing factor a and transforming growth factor-β. J Biol Chem 1986, 261, 12362-12367.
29. 29. Lamarre J, Vasudevan J, Gonias SL. Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface. Biochem J 1994, 302, 199-205.
30. 30. Bonewald LF, Wakefield L, Oreffo ROC, Escobedo A, Twardzik DR, Mundy GR. Latent forms of transforming growth factor-β (TGF-β) derived from bone cultures: identification of a naturally occurring 100 kDa complex with similarity to recombinant latent TGF-β. Mol Endocrinol 1991, 5, 741-751.
31. 31. Uchiumi T, Mizoguchi H, Hagino Y, Kohno K, Kuwano M. Counteraction of estradiol induced activation of tissue-type plasminogen activator in a human breast cancer cell line by an anti-estrogen Ly 117018. Int J Cancer 1991, 47, 80-85.
32. 32. Kovacina KS, Steele Perkins G, Purchio AF, et al. Interactions of recombinant and platelet transforming growth factor-beta 1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem Biophys Res Commun 1989, 160, 393-403.
33. 1 and a different tissue distribution. J Clin Invest 1990, 86, 1976-1984.